Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled Study

Objective. To examine the efficacy and safety of ozonated autohemotherapy (O3-AHT) combined with pharmacological therapy for comorbid insomnia and myofascial pain syndrome (MPS). Materials and Methods. One hundred and eighteen patients were randomly divided into two groups: the control group (N = 50...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Shen, Ning Liu, Zhonghua Ji, Hongwei Fang, Feng Liu, Wei Zhang, Xiuqin Yu, Mingxia Wang, Jinyuan Zhang, Xiangrui Wang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Pain Research and Management
Online Access:http://dx.doi.org/10.1155/2022/3562191
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849698215648034816
author Wang Shen
Ning Liu
Zhonghua Ji
Hongwei Fang
Feng Liu
Wei Zhang
Xiuqin Yu
Mingxia Wang
Jinyuan Zhang
Xiangrui Wang
author_facet Wang Shen
Ning Liu
Zhonghua Ji
Hongwei Fang
Feng Liu
Wei Zhang
Xiuqin Yu
Mingxia Wang
Jinyuan Zhang
Xiangrui Wang
author_sort Wang Shen
collection DOAJ
description Objective. To examine the efficacy and safety of ozonated autohemotherapy (O3-AHT) combined with pharmacological therapy for comorbid insomnia and myofascial pain syndrome (MPS). Materials and Methods. One hundred and eighteen patients were randomly divided into two groups: the control group (N = 50) and the O3-AHT group (N = 53). Patients in both groups were given the same pharmacological management for three weeks. Patients in the O3-AHT group were treated with ozonated autohemotherapy (the concentration of ozone was 20 µg/ml in the first week, 30 µg/ml in the second week, and 40 µg/ml in the third week) combined with pharmacological therapy. Primary (the insomnia severity index (ISI) and visual analogue scale (VAS)) and secondary outcomes (the Epworth sleepiness scale (ESS), polysomnography data, the anxiety and preoccupation about sleep questionnaire (APSQ), the beck depression index (BDI), and the multidimensional fatigue inventory (MFI)) were examined at pretreatment, posttreatment, 1 month, and 6 months. Results. Fifty patients in the control group and fifty-three patients in the O3-AHT group completed the study. In both groups, insomnia and pain symptoms were relieved significantly compared with pretreatment. Compared with the control group, the O3-AHT group had significantly improved sleep quality, pain, and negative mood at different time points. No adverse complications were observed in either group. Conclusion. Compared with pharmacological therapy alone, ozonated autohemotherapy combined with pharmacological therapy can ameliorate insomnia, reduce pain intensity, improve negative mood, and alleviate fatigue more effectively without serious adverse complications.
format Article
id doaj-art-a1d02d22ba6b42aeb0cce4356ea670ce
institution DOAJ
issn 1918-1523
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Pain Research and Management
spelling doaj-art-a1d02d22ba6b42aeb0cce4356ea670ce2025-08-20T03:18:58ZengWileyPain Research and Management1918-15232022-01-01202210.1155/2022/3562191Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled StudyWang Shen0Ning Liu1Zhonghua Ji2Hongwei Fang3Feng Liu4Wei Zhang5Xiuqin Yu6Mingxia Wang7Jinyuan Zhang8Xiangrui Wang9Department of PainDepartment of AnesthesiologyDepartment of AnesthesiologyDepartment of AnesthesiologyDepartment of PainDepartment of AnesthesiologyDepartment of PainDepartment of PainDepartment of PainDepartment of PainObjective. To examine the efficacy and safety of ozonated autohemotherapy (O3-AHT) combined with pharmacological therapy for comorbid insomnia and myofascial pain syndrome (MPS). Materials and Methods. One hundred and eighteen patients were randomly divided into two groups: the control group (N = 50) and the O3-AHT group (N = 53). Patients in both groups were given the same pharmacological management for three weeks. Patients in the O3-AHT group were treated with ozonated autohemotherapy (the concentration of ozone was 20 µg/ml in the first week, 30 µg/ml in the second week, and 40 µg/ml in the third week) combined with pharmacological therapy. Primary (the insomnia severity index (ISI) and visual analogue scale (VAS)) and secondary outcomes (the Epworth sleepiness scale (ESS), polysomnography data, the anxiety and preoccupation about sleep questionnaire (APSQ), the beck depression index (BDI), and the multidimensional fatigue inventory (MFI)) were examined at pretreatment, posttreatment, 1 month, and 6 months. Results. Fifty patients in the control group and fifty-three patients in the O3-AHT group completed the study. In both groups, insomnia and pain symptoms were relieved significantly compared with pretreatment. Compared with the control group, the O3-AHT group had significantly improved sleep quality, pain, and negative mood at different time points. No adverse complications were observed in either group. Conclusion. Compared with pharmacological therapy alone, ozonated autohemotherapy combined with pharmacological therapy can ameliorate insomnia, reduce pain intensity, improve negative mood, and alleviate fatigue more effectively without serious adverse complications.http://dx.doi.org/10.1155/2022/3562191
spellingShingle Wang Shen
Ning Liu
Zhonghua Ji
Hongwei Fang
Feng Liu
Wei Zhang
Xiuqin Yu
Mingxia Wang
Jinyuan Zhang
Xiangrui Wang
Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled Study
Pain Research and Management
title Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled Study
title_full Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled Study
title_fullStr Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled Study
title_full_unstemmed Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled Study
title_short Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled Study
title_sort combining ozonated autohemotherapy with pharmacological therapy for comorbid insomnia and myofascial pain syndrome a prospective randomized controlled study
url http://dx.doi.org/10.1155/2022/3562191
work_keys_str_mv AT wangshen combiningozonatedautohemotherapywithpharmacologicaltherapyforcomorbidinsomniaandmyofascialpainsyndromeaprospectiverandomizedcontrolledstudy
AT ningliu combiningozonatedautohemotherapywithpharmacologicaltherapyforcomorbidinsomniaandmyofascialpainsyndromeaprospectiverandomizedcontrolledstudy
AT zhonghuaji combiningozonatedautohemotherapywithpharmacologicaltherapyforcomorbidinsomniaandmyofascialpainsyndromeaprospectiverandomizedcontrolledstudy
AT hongweifang combiningozonatedautohemotherapywithpharmacologicaltherapyforcomorbidinsomniaandmyofascialpainsyndromeaprospectiverandomizedcontrolledstudy
AT fengliu combiningozonatedautohemotherapywithpharmacologicaltherapyforcomorbidinsomniaandmyofascialpainsyndromeaprospectiverandomizedcontrolledstudy
AT weizhang combiningozonatedautohemotherapywithpharmacologicaltherapyforcomorbidinsomniaandmyofascialpainsyndromeaprospectiverandomizedcontrolledstudy
AT xiuqinyu combiningozonatedautohemotherapywithpharmacologicaltherapyforcomorbidinsomniaandmyofascialpainsyndromeaprospectiverandomizedcontrolledstudy
AT mingxiawang combiningozonatedautohemotherapywithpharmacologicaltherapyforcomorbidinsomniaandmyofascialpainsyndromeaprospectiverandomizedcontrolledstudy
AT jinyuanzhang combiningozonatedautohemotherapywithpharmacologicaltherapyforcomorbidinsomniaandmyofascialpainsyndromeaprospectiverandomizedcontrolledstudy
AT xiangruiwang combiningozonatedautohemotherapywithpharmacologicaltherapyforcomorbidinsomniaandmyofascialpainsyndromeaprospectiverandomizedcontrolledstudy